Literature DB >> 22832321

Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.

Rachid Skouta1, Miki Hayano, Kenichi Shimada, Brent R Stockwell.   

Abstract

A series of Pictet-Spengler condensation derivatives (tetrahydro-β-carbolines) was designed, synthesized and evaluated for lethality against a panel of seven cancer cell lines. Seven compounds (2a, 13, 20, 21, 27, 29 and 34) showed lethality in at least five cell lines. Among these, compound 27 showed a unique selectivity towards oncogenic-RAS expressing BJ-TERT/LT/ST/RAS(V12) tumor cells, compared to non-transformed BJ-TERT cells. Further investigation revealed that 27 induces cell death without activation of caspases. This represents a useful new probe of non-apoptotic cell death and oncogenic-RAS synthetic lethality.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832321      PMCID: PMC3423582          DOI: 10.1016/j.bmcl.2012.06.077

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

1.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.

Authors:  Sonam Dolma; Stephen L Lessnick; William C Hahn; Brent R Stockwell
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

2.  Erlotinib hydrochloride.

Authors:  Jonathan Dowell; John D Minna; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2005-01       Impact factor: 84.694

3.  Beta-carbolines as specific inhibitors of cyclin-dependent kinases.

Authors:  Yongcheng Song; Jian Wang; Su Fern Teng; Djohan Kesuma; Yu Deng; Jinao Duan; Jerry H Wang; Robert Zhong Qi; Mui Mui Sim
Journal:  Bioorg Med Chem Lett       Date:  2002-04-08       Impact factor: 2.823

4.  Antitumor agents 201. Cytotoxicity of harmine and beta-carboline analogs.

Authors:  J Ishida; H K Wang; K F Bastow; C Q Hu; K H Lee
Journal:  Bioorg Med Chem Lett       Date:  1999-12-06       Impact factor: 2.823

Review 5.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

Review 7.  Integrating genetic approaches into the discovery of anticancer drugs.

Authors:  L H Hartwell; P Szankasi; C J Roberts; A W Murray; S H Friend
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

8.  Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.

Authors:  F Leteurtre; J Madalengoitia; A Orr; T J Guzi; E Lehnert; T Macdonald; Y Pommier; T J Cuzi
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

Review 9.  The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer.

Authors:  M E O'Dwyer; B J Druker
Journal:  Curr Cancer Drug Targets       Date:  2001-05       Impact factor: 3.428

10.  Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2.

Authors:  J E Nutt; H P Lazarowicz; J K Mellon; J Lunec
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more
  7 in total

1.  Design, Synthesis and Biological Evaluation of β-Carboline Dimers Based on the Structure of Neokauluamine.

Authors:  Jaruwan Chatwichien; Subhasree Basu; Maureen E Murphy; Mark T Hamann; Jeffrey D Winkler
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major.

Authors:  Eva A Iniguez; Andrea Perez; Rosa A Maldonado; Rachid Skouta
Journal:  Bioorg Med Chem Lett       Date:  2015-09-22       Impact factor: 2.823

3.  Convenient construction of tetrahydrochromeno[4',3':2,3]indolizino[8,7-b]indoles and tetrahydroindolizino[8,7-b]indoles via one-pot domino reaction.

Authors:  Jing Sun; Wang Jiang; Chao-Guo Yan
Journal:  RSC Adv       Date:  2018-08-14       Impact factor: 3.361

4.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

5.  Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.

Authors:  Min-Young Kwon; Eunhee Park; Seon-Jin Lee; Su Wol Chung
Journal:  Oncotarget       Date:  2015-09-15

Review 6.  Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents.

Authors:  Jyothi Dhuguru; Rachid Skouta
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

Review 7.  The Pictet-Spengler Reaction Updates Its Habits.

Authors:  Andrea Calcaterra; Laura Mangiardi; Giuliano Delle Monache; Deborah Quaglio; Silvia Balducci; Simone Berardozzi; Antonia Iazzetti; Roberta Franzini; Bruno Botta; Francesca Ghirga
Journal:  Molecules       Date:  2020-01-19       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.